SGLT-2 inhibitors, a relatively new classification of medications used primarily in the treatment of type 2 diabetes, also have implications for use in individuals with chronic kidney disease. Learn more about SGLT-2 inhibitors, dosing for patients with renal disease, possible side effects, cost, and potential funding sources for renal patients who may benefit from treatment with these medications.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will describe how a drug used to manage type 2 diabetes may have implications and possible side effects for individuals with chronic kidney disease.
This session addresses the status of human trafficking in the United States and how behavioral intelligence can be used to identify victims. Learn how healthcare professionals can help to identify and report human trafficking in order to protect and assist victims of this crime.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will describe how to identify signs of human trafficking and reporting procedures for healthcare providers.
Sexual dysfunction is common in men and women with chronic kidney disease. This session reviews sexual issues that may impact individuals with kidney disease, tips for discussing this potentially sensitive topic with patients, and treatment options and resources for male and female sexual dysfunction.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will state an increased comfort in discussing commonly experienced sexual challenges and treatment options for patients with CKD.
The 2019 Executive Order on Advancing American Kidney Health set an ambitious goal for increasing home dialysis in the end-stage kidney disease (ESKD) patient population. This session examines best practices for early referral for home dialysis following a review of current renal replacement therapy status. Current strategies and future opportunities for increasing home dialysis options are explored.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Speaker: Molly Cahill – Amgen, OPKO, Otsuka Speakers Bureau; Consultant, Otsuka
The speaker would like to apologize and make you aware that Roxadustat (FibroGen) was not approved in the US as expected due to COVID-19 delays and is now expected in early December. The speaker acknowledges no financial relationships with it or any of the new HIF anemia products she spoke about in this presentation.
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will state best practices that lead to early referrals to explore home dialysis options for patients with CKD.
If you are interested in learning how to start a research project, this session is for you! After reviewing the history of landmark nursing research and how it has shaped our profession, Dr. Cupples provides tips for developing a research project and discuss the necessary resources for conducting nursing research.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will be able to outline a research study development and initiation plan.
Learn more about the incidence and risk factors for venous thromboembolism (VTE) in chronic kidney disease. Discussion includes diagnostic evaluations to determine VTE, therapeutic management (both pharmacologic and nonpharmacologic), and medications with renal dosing considerations.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will state an increased ability to educate patients with CKD about the risk factors, symptoms, and management of VTE.
While under 20% of all workplace injuries happen to healthcare workers, healthcare workers suffer 50% of all assaults. These numbers continue to rise and could play a significant role in the future of nursing. If the issue of workplace violence is not addressed and strategies put in place to reduce the risks nurses face, then more nurses will leave the profession – either as a result of their own trauma, or from indirect trauma as a result of witnessing an assault on a coworker. This session defines workplace violence in the healthcare setting and focus on prevalence and prevention strategies. It also covers employee rights and offer numerous resources nurses can take back to their employers for designing and implementing a workplace violence prevention program.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will describe the prevalence of workplace injuries, as well as the rights employees have once an injury occurs.
Burnout has affected nurses for years and 2020 has certainly amplified the stress of nurses caring for patients. This session explores types of burnout and strategies to help manage and prevent nurse burnout.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will describe the prevalence and symptoms of nurse burnout and strategies to address and prevent burnout.
Dr. Shaffer provides a background of activities and initiatives surrounding 2020 The International Year of the Nurse and the Midwife. He then explores the implications to nephrology nursing practice and predictions for the future, particularly in light of the challenges confronting health care in 2020.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of the activity the learner will discuss the Year of the Nurse and potential implications for nephrology nursing.
Treatment options for severe heart failure include left ventricular assist devices (LVADs) and extra-corporeal membrane oxygenation (ECMO) are discussed. As nephrology nurses care for patients at risk for heart failure, it is important to understand the indications for the use of these devices and how they work. Learn more about the nursing care for patients with LVADs/ECMO and potential treatment complications.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will state an ability to plan care for a patient with an LVAD or receiving ECMO for heart failure, the goals of therapy, potential complications, and specific nursing interventions.
Peripheral vascular disease - both arterial and venous - can have devastating consequences for persons with chronic kidney disease (CKD). This session reviews assessment of arterial and venous vascular disease, nursing interventions, and evidence-based pharmacologic and non-pharmacologic treatment.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Speaker: Kristin Larson – Employee, United Health Group, Astra Zeneca Speakers Bureau
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the nephrology nurse will be able to discuss the evidence available to plan and provide nursing care to a patient with PVD and PKD.
This session explores opportunities for advanced practice nurses to maximize their impact in various nephrology settings, including office-based clinics, outpatient dialysis, and acute care, in order to maximize reimbursement opportunities.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Speaker: Leah Foster Smith – Senior Consultant, Clear Edge Medical Management; Owner and Chief Education Officer, Interactive Nephrology
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will describe methods that have the potential to maximize reimbursement for the AP employed in various nephrology settings.
This session focuses on the impact and pattern of emerging infections – both bacterial and viral. Antibiotic resistance, implications for treatment and management, and vaccine development are discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will be able to discuss the impact and pattern of emerging bacterial and viral infections, antibiotic resistance, vaccine development, and the role healthcare providers play in infection prevention.
This session focuses on current hot topics in pediatric nephrology care and issues surrounding the transition from pediatric to adult care for nephrology patients.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will state an ability to care for pediatric clients transitioning from a pediatric to adult nephrology setting.
This session includes a discussion of the etiology, incidence, prevalence, and risk factors for acute kidney injury. The RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) and Acute Kidney Injury Network (AKIN) classifications, treatment options, and patient outcomes are also reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will describe the pathophysiology of AKI and the nursing interventions employed to care for a patient with this condition.
Access devices continue to evolve, and this session focuses on newer access devices such as the HeRO® graft and percutaneous fistula. Discussion addresses access placement, opportunities for earlier use in patients compared to other options, postoperative care, and access maintenance.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Speaker: Peter Hathaway – Consultant, Merit Medical Systems
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completing this session the learner will describe innovative vascular access devices created for hemodialysis and the maintenance and care required.
Sponsored by Amgen.
Sponsored by Rockwell.
Hear from experts about a novel physiologic approach to iron maintenance therapy that delivers 100% bioavailable iron resulting in hemoglobin stability.1,*
Practical applications and the clinical profile of a novel therapy for iron maintenance therapy in adults with HDD-CKD will be reviewed and discussed.
*In two Phase 3 clinical studies, the hemoglobin remained stable (at baseline levels) in patients treated with ferric pyrophosphate citrate while hemoglobin levels declined in placebo-treated patients.2
1. Pratt RD, et al. J Clin Pharmacol. 2017;57(3):312-320.
2. Fishbane SN, et al. Nephrol Dial Transplant. 2015;30(12):2019-2026.
This session focuses on current fad diets and health-related warning signs we should watch for in our patients, our colleagues, and ourselves. How do you know if a diet is healthy? What impact does the diet have on renal function? Learn important information you can share with patients and colleagues about fad diets.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will be able to describe health care considerations related to fad diets.
If you are interested in creating an apheresis program at your facility, this session is for you! The session covers the fundamental requirements to start an apheresis program as well as the importance of determining the appropriate patient population for this treatment. Considerations related to budgeting, equipment, supplies, staffing, billing, and reimbursement are also reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completing this session the learner will describe the elements needed to develop an apheresis program including staff, budget, equipment, and patient care considerations.
Adrenal pathologies are not uncommon in individuals with renal disease. This session provides an overview of adrenal hormones, pathologies causing increased or decreased secretion of these hormones, evaluation of adrenal function in patients, and therapeutic management of adrenal pathologies.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will compare and contrast hyperfunction and hypofunction of the adrenal glands including patient assessment findings and the therapeutic management.
The health and well-being of nurses are central to the delivery of safe nursing care and retention of nurses in all areas of practice. In the Year of the Nurse and in the midst of a global pandemic, there is no better time to identify ways to support nurses’ mental health and overall well-being. Findings from a national survey of nephrology nurses provide a basis for exploring this topic.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 11/8/2022.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Speaker: Myrlene Sanon – Employee, Otsuka
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will describe the findings and implications of a research study that investigated the mental health and wellbeing of nephrology nurses.
Learn more about beta 2-microglobulin amyloidosis, a condition that may affect individuals who have been receiving long-term dialysis. The symptoms, incidence, and prevalence of this disease process as well as the differential diagnosis and treatment options are reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will describe the pathophysiology Beta 2 microglobin amyloidosis in the patient population receiving dialysis and implications for nursing care.
This session reviews the anticipated need for nurses in the healthcare system in the midst of a growing nursing shortage. The impact of the shortage on staffing in nephrology and strategies to decrease that deficit are explored. A highlight is the discussion of the driving forces in the nephrology nursing shortage, such as staffing ratios, increased acuity, and loss of experienced nurses.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this session the learner will discuss the factors that contribute to the nephrology nursing shortage and interventions to address this workforce issue.
Nephrology nurses travel varied paths throughout their nursing careers. During this session, Dr. Hale shares her unique nursing career journey. Starting at the "bottom of the rung" as a nephrology nurse in dialysis, the journey included earning an MBA and working to improve the care and lives of patients on dialysis. While nephrology nurses’ career paths vary, listening to another nurse’s journey triggers our own memories of career challenges and choices. Participate in this session to relive your own journey and discover new possibilities – or to revisit the journey of a fellow nephrology nurse.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.
ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity the learner will state the benefits of and strategies to promote professional growth, development, and advancement.